Adherium Ltd. (AU:ADR) has released an update.
Adherium Ltd., a leading digital health firm, is set to showcase its Hailie® sensor and medication adherence technology at the prestigious 2024 American Thoracic Society (ATS) International Conference in San Diego, with attendance by key company executives including CEO Dr. Paul Mastoridis. The conference is a premier event for pulmonary, critical care, and sleep health professionals, providing Adherium with an opportunity to increase visibility and promote the now U.S. reimbursed Hailie® Smartinhaler® to a large audience of over 14,000 attendees. Dr. Mastoridis aims to network with industry peers and highlight the patient impact of Adherium’s technologies in improving medication adherence.
For further insights into AU:ADR stock, check out TipRanks’ Stock Analysis page.
